NCT01467674 is a clinical trial in Type 2 Diabetes Mellitus, sponsored by Suleyman Demirel University.

Who is sponsoring NCT01467674?

NCT01467674 is sponsored by Suleyman Demirel University.

What condition does NCT01467674 study?

NCT01467674 studies Type 2 Diabetes Mellitus, Chronic Periodontitis.

Is NCT01467674 still recruiting?

NCT01467674 is currently completed. Last updated 8 November 2011.

Last reviewed 2011-11-08 · How we verify

NCT01467674

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Malondialdehyde And Antioxidant Levels In Chronic Periodontitis Patients With Type 2 Diabetes Mellitus Under Different Stages Of Metabolic Control

Completed Last updated 8 November 2011

What this trial tests

trial in Type 2 Diabetes Mellitus in 84 participants. Completed in 1 May 2009.

Timeline

1 January 2008

Primary endpoint
1 May 2009

1 May 2009

Quick facts

Lead sponsor	Suleyman Demirel University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	84
Start date	1 January 2008
Primary completion	1 May 2009
Estimated completion	1 May 2009
Sites	1 location across Turkey (Türkiye)

Conditions studied

Type 2 Diabetes Mellitus — all drugs for Type 2 Diabetes Mellitus →
Chronic Periodontitis — all drugs for Chronic Periodontitis →

Sponsor

Suleyman Demirel University

Who can join

Eligibility, any sex, with Type 2 Diabetes Mellitus or Chronic Periodontitis. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

HbA1c
Time frame: One Year
Level of Metabolic Control

Sponsor's own description

The aim of this study was to investigate the impact of glycemic control on clinical periodontal status, levels of malondialdehyde (MDA), glutathione peroxidase (GSH-Px), reduced glutathione (GSH) and paraoxonase (PON) activity in gingival crevicular fluid (GCF) and blood samples of type 2 diabetes mellitus (T2DM) patients with chronic periodontitis (CP).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Amphibians as a source of bioactive antioxidant peptides: Emerging insights and therapeutic potential.
Zhu YY, Zhao LM, Jia XY, Liao GJ, et al · · 2025 · PMID 41017405 · DOI 10.24272/j.issn.2095-8137.2025.127

Verify or expand the search:

Other recruiting trials for Type 2 Diabetes Mellitus

Currently open trials in the same condition.

NCT07351058 — A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Diabetes · Phase 3 · recruiting
NCT07373938 — Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus · recruiting
NCT07433062 — A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With · Phase 1 · recruiting
NCT07276776 — An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes · NA · active not recruiting
NCT07232537 — An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic · recruiting

Other Suleyman Demirel University trials

Trials by the same sponsor.

NCT07429513 — Promoting Environmental Responsibility Toward Climate Change · NA · not yet recruiting
NCT07523087 — Effect of a Brief Mindfulness-Based Training on First Clinical Day Stress in First-Year Nursing Students · NA · completed
NCT07245355 — Contribution of Recreational Exercises to Balance and Muscle Strength in Osteoporosis Risk · NA · not yet recruiting
NCT07333391 — Individualized Grief Support With Swanson Model · NA · not yet recruiting
NCT07382830 — Effectiveness of a Visual Feedback Exercise Program Following Lumbar Surgery · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01467674 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Suleyman Demirel University
Last refreshed: 8 November 2011

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01467674.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing